Suzhou Transcenta Therapeutics Co., Ltd.

This early-stage study tests a new drug called TST003 in about 111 adults with advanced solid tumors (cancers that have spread or cannot be removed by surgery). The main goals are to find a safe dose, check side effects, and see if the drug can shrink tumors. Participants receive…

This early-phase trial tests a new drug called TST001, an antibody that targets a protein (CLDN18.2) found on some cancer cells. It is being studied alone or with other treatments in about 150 people with advanced stomach, esophageal, or pancreatic cancers that have not responded…